Stockreport

Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Autolus Therapeutics plc - American Depositary Shares  (AUTL) 
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am Check Earnings Report
US:NASDAQ Investor Relations: autolus.com/investor-relations
PDF Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClin [Read more]